NUTRITION 21 has a total of 61 patent applications. Its first patent ever was published in 1980. It filed its patents most often in United States, Israel and Australia. Its main competitors in its focus markets pharmaceuticals, machines and foods and drinks are GORBACH SHERWOOD L, EMERAMED LTD and KURINTETSUKU NIYUUTORISHIYON C.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 17 | |
#2 | Israel | 7 | |
#3 | Australia | 6 | |
#4 | EPO (European Patent Office) | 5 | |
#5 | WIPO (World Intellectual Property Organization) | 5 | |
#6 | Brazil | 4 | |
#7 | China | 3 | |
#8 | Czechia | 3 | |
#9 | Canada | 2 | |
#10 | Mexico | 2 | |
#11 | Norway | 2 | |
#12 | Poland | 2 | |
#13 | Argentina | 1 | |
#14 | Hungary | 1 | |
#15 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Foods and drinks | |
#4 | Organic fine chemistry | |
#5 | Measurement | |
#6 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Foods | |
#5 | Special acyclic compounds | |
#6 | Specific use of cosmetics | |
#7 | Enzymes | |
#8 | Analysing materials | |
#9 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Mccarty Mark F | 31 |
#2 | Zielinski Jan | 9 |
#3 | Evans Gary W | 7 |
#4 | Mccarty Mark | 5 |
#5 | Peppler Henry J | 4 |
#6 | Bakal Abraham I | 3 |
#7 | Murphy Ellen | 3 |
#8 | Archer Gordon | 3 |
#9 | Climo Michael | 3 |
#10 | Snyder Margaret A | 3 |
Publication | Filing date | Title |
---|---|---|
AU2002302012B2 | Chromim/biotin treatment of type II diabetes | |
US6099869A | Calcium taurate and antihypertensive drug for hypertension | |
AU8765198A | Chromium/biotin treatment of type II diabetes | |
CZ278799A3 | Arginine-silicate-inositol complex and use thereof | |
US5789401A | High-dose chromium/biotin treatment of type II diabetes | |
US5707970A | Arginine silicate complex and use thereof | |
CN1189776A | High-dose chromic tripicolinate for the treatment of type II diabetes | |
US5776498A | Magnesium taurate as an adjuvant to rapid thrombolytic therapy | |
US6329361B1 | High-dose chromic picolinate treatment of type II diabetes | |
US5582839A | Magnesium taurate and other mineral taurates | |
US5175156A | Chromic picolinate treatment | |
US5087624A | Chromic picolinate treatment | |
US5057320A | Means and method for increasing skin respiration | |
US4997765A | Microorganism growth acceleration | |
US4341757A | Stable isotopic immunoassay method employing non-radioactive selenium label |